Development of a Long Acting and Stapled Dual Amylin and Calcitonin Receptor Agonist as Monotherapy and Combination with GLP 1R Agonists for the Treatment of Obesity Bioconjugate Chemistry Glucagon Like Peptide 1 Receptor Agonists and Suicidality: Association Versus Causation and the Need for Ongoing Surveillance American Journal of Psychiatry Incretin hormone agonists: Current and emerging pharmacotherapy for obesity management Alhomoud 2024 Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy Wiley Online Library An investigational injectable that only requires dosing once every 4 weeks led to substantial weight loss in patients with obesity with or without type 2 diabetes, a phase II randomized trial showed.